4.3 Article

The effects of a glycine reuptake inhibitor R231857 on the central nervous system and on scopolamine-induced impairments in cognitive and psychomotor function in healthy subjects

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Glutamate and dopamine dysregulation in schizophrenia - A synthesis and selective review

James M. Stone et al.

JOURNAL OF PSYCHOPHARMACOLOGY (2007)

Review Endocrinology & Metabolism

Regulatory role of excitatory amino acids in reproduction

VB Mahesh et al.

ENDOCRINE (2005)

Article Behavioral Sciences

Muscarinic and nicotinic receptor modulation of object and spatial n-back working memory in humans

A Green et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2005)

Article Pharmacology & Pharmacy

Biomarkers for the effects of benzodiazepines in healthy volunteers

SJ de Visser et al.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2003)

Article Behavioral Sciences

Effects of scopolamine and D-cycloserine on non-spatial reference memory in rats

JM Andersen et al.

BEHAVIOURAL BRAIN RESEARCH (2002)

Article Clinical Neurology

Saccadic peak velocity and EEG as end-points for a serotonergic challenge test

HJ Gijsman et al.

HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2002)

Article Pharmacology & Pharmacy

Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers

U Ebert et al.

JOURNAL OF CLINICAL PHARMACOLOGY (2001)